Terra Wonsettler, PharmD, MBA, vice president of pharmacy for Evolent, discusses the recent HHS OIG report that stemmed from ...

The removal of FDA guidance on clinical trial diversity and related anti–diversity, equity, and inclusion (DEI) actions may hinder progress toward equitable health care, impacting workforce diversity, ...

However, we still see areas of weakness in the portfolio, including upcoming patent losses and a highly uncertain pipeline due to the complexities of running CNS trials. Historically, the firm ...

The Trump administration’s overarching message to the legions of people powering the federal government is simple: Leave.

The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.

The recipient was Tim Andrews, a 66-year-old New Hampshire resident who had end-stage kidney disease and was on dialysis for ...

New licensing Guidelines issued by the National Institutes of Health at the end of the Biden Administration could harm ...

Many people will be staying up late this weekend to watch the Super Bowl, which might make Monday morning a little rougher ...